|
1
|
Saengtipbovorn S and Taneepanichskul S:
Lifestyle Change Plus Dental Care (LCDC) program improves
knowledge, attitude, and practice (KAP) toward oral health and
diabetes mellitus among the elderly with type 2 diabetes. J Med
Assoc Thai. 98:279–290. 2015.PubMed/NCBI
|
|
2
|
Barrett HL, Nitert M Dekker, Jones L,
O'Rourke P, Lust K, Gatford KL, De Blasio MJ, Coat S, Owens JA,
Hague WM, et al: Determinants of maternal triglycerides in women
with gestational diabetes mellitus in the Metformin in Gestational
Diabetes (MiG) study. Diabetes Care. 36:1941–1946. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jorgensen CH, Gislason GH, Ahlehoff O,
Andersson C, Torp-Pedersen C and Hansen PR: Use of secondary
prevention pharmacotherapy after first myocardial infarction in
patients with diabetes mellitus. BMC Cardiovasc Disord. 14:42014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harashima SI, Ogura M, Tanaka D, Fukushima
T, Wang Y, Koizumi T, Aono M, Murata Y, Seike M and Inagaki N:
Sitagliptin add-on to low dosage sulphonylureas: Efficacy and
safety of combination therapy on glycaemic control and insulin
secretion capacity in type 2 diabetes. Int J Clin Pract.
66:465–476. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wongchareon W, Phrommintikul A,
Kanjanavanit R, Kuanprasert S and Sukonthasarn A: A predictive
model for distinguishing ischemic from non-ischemic cardiomyopathy.
J Med Assoc Thai. 88:1689–1696. 2005.PubMed/NCBI
|
|
6
|
Barsotti A, Giannoni A, Di Napoli P and
Emdin M: Energy metabolism in the normal and in the diabetic heart.
Curr Pharm Des. 15:836–840. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abu-Sulaiman RM and Subaih B: Congenital
heart disease in infants of diabetic mothers: Echocardiographic
study. Pediatr Cardiol. 25:137–140. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mann GE: Nrf2-mediated redox signalling in
vascular health and disease. Free Radic Biol Med. 75 Suppl
1:S12014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Hu X, Xie J, Xu W and Jiang H:
Beta-1-adrenergic receptors mediate Nrf2-HO-1-HMGB1 axis regulation
to attenuate hypoxia/reoxygenation-induced cardiomyocytes injury in
vitro. Cell Physiol Biochem. 35:767–777. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang G, Liu X, Wang M, Chen H, Chen Z and
Qiu T: Oxymatrine ameliorates renal ischemia-reperfusion injury
from oxidative stress through Nrf2/HO-1 pathway. Acta Cir Bras.
30:422–429. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu J, Wang X, Liu R, Liu Y, Zhang T, Fu H
and Hai C: Oleanolic acid co-administration alleviates
ethanol-induced hepatic injury via Nrf-2 and ethanol-metabolizing
modulating in rats. Chem Biol Interact. 221:88–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu K, Chu F, Li G, Xu X, Wang P, Song J,
Zhou S and Lei H: Oleanolic acid synthetic oligoglycosides: A
review on recent progress in biological activities. Pharmazie.
69:483–495. 2014.PubMed/NCBI
|
|
13
|
Shanmugam MK, Dai X, Kumar AP, Tan BK,
Sethi G and Bishayee A: Oleanolic acid and its synthetic
derivatives for the prevention and therapy of cancer: Preclinical
and clinical evidence. Cancer Lett. 346:206–216. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mukundwa A, Mukaratirwa S and Masola B:
Effects of oleanolic acid on the insulin signaling pathway in
skeletal muscle of streptozotocin-induced diabetic male
Sprague-Dawley rats. J Diabetes. 8:98–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Falcao-Pires I and Leite-Moreira AF:
Diabetic cardiomyopathy: Understanding the molecular and cellular
basis to progress in diagnosis and treatment. Heart Fail Rev.
17:325–344. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie Z, He C and Zou MH: AMP-activated
protein kinase modulates cardiac autophagy in diabetic
cardiomyopathy. Autophagy. 7:1254–1255. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai L, Wang Y, Zhou G, Chen T, Song Y, Li
X and Kang YJ: Attenuation by metallothionein of early cardiac cell
death via suppression of mitochondrial oxidative stress results in
a prevention of diabetic cardiomyopathy. J Am Coll Cardiol.
48:1688–1697. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kajstura J, Fiordaliso F, Andreoli AM, Li
B, Chimenti S, Medow MS, Limana F, Nadal-Ginard B, Leri A and
Anversa P: IGF-1 overexpression inhibits the development of
diabetic cardiomyopathy and angiotensin II-mediated oxidative
stress. Diabetes. 50:1414–1424. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang C, Zhang L, Chen S, Feng B, Lu X,
Bai Y, Liang G, Tan Y, Shao M, Skibba M, et al: The prevention of
diabetic cardiomyopathy by non-mitogenic acidic fibroblast growth
factor is probably mediated by the suppression of oxidative stress
and damage. PLoS One. 8:e822872013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tian C, Ouyang X, Lv Q, Zhang Y and Xie W:
Cross-talks between microRNAs and mRNAs in pancreatic tissues of
streptozotocin-induced type 1 diabetic mice. Biomed Rep. 3:333–342.
2015.PubMed/NCBI
|
|
21
|
Badole SL, Jangam GB, Chaudhari SM, Ghule
AE and Zanwar AA: L-glutamine supplementation prevents the
development of experimental diabetic cardiomyopathy in
streptozotocin-nicotinamide induced diabetic rats. PLoS One.
9:e926972014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Selim ME, Abd-Elhakim YM and Al-Ayadhi LY:
Pancreatic response to gold nanoparticles includes decrease of
oxidative stress and inflammation in autistic diabetic model. Cell
Physiol Biochem. 35:586–600. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sarkar C, Pal S, Das N and Dinda B:
Ameliorative effects of oleanolic acid on fluoride induced
metabolic and oxidative dysfunctions in rat brain: Experimental and
biochemical studies. Food Chem Toxicol. 66:224–236. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeng X, Li J and Li Z: Ginsenoside Rd
mitigates myocardial ischemia-reperfusion injury via Nrf2/HO-1
signaling pathway. Int J Clin Exp Med. 8:14497–14504.
2015.PubMed/NCBI
|
|
25
|
Lappalainen J, Lappalainen Z, Oksala NK,
Laaksonen DE, Khanna S, Sen CK and Atalay M: Alpha-lipoic acid does
not alter stress protein response to acute exercise in diabetic
brain. Cell Biochem Funct. 28:644–650. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hong YA, Lim JH, Kim MY, Kim EN, Koh ES,
Shin SJ, Choi BS, Park CW, Chang YS and Chung S: Delayed treatment
with oleanolic acid attenuates tubulointerstitial fibrosis in
chronic cyclosporine nephropathy through Nrf2/HO-1 signaling. J
Transl Med. 12:502014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang Y, Zhang J, Liu H and Zhang L: Change
of Nrf2 expression in rat hippocampus in a model of chronic
cerebral hypoperfusion. Int J Neurosci. 124:577–584. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Soares MP and Ribeiro AM: Nrf2 as a master
regulator of tissue damage control and disease tolerance to
infection. Biochem Soc Trans. 43:663–668. 2015. View Article : Google Scholar : PubMed/NCBI
|
